{
    "type": "ETF",
    "ucits": true,
    "fund_name": "Amundi Global Bioenergy UCITS ETF EUR Acc",
    "investment_objective": "Track the Bloomberg BioEnergy Screened Index with ESG characteristics, minimizing tracking error",
    "primary_asset_class": "Equity",
    "geographic_focus": "International, with top exposures in United States, Finland, France, Italy, Denmark, Germany, Canada, UK, Switzerland, China",
    "replication_method": "physical",
    "swaps": false,
    "derivatives": false,
    "leverage": false,
    "inverse": false,
    "complex_factors": [],
    "classification": "non-complex",
    "supporting_data": "The ETF is a UCITS fund using physical replication to track the Bloomberg BioEnergy Screened Index, investing directly in equities of companies involved in bioenergy production and distribution. The KIID and PRIIPs KID confirm the use of direct investments with only limited derivative use for operational purposes such as managing inflows/outflows or local market specifics, not as an inherent part of the investment strategy. There is no mention of synthetic replication, swap agreements, or funded/unfunded swaps. Leverage or inverse exposure is not present. The risk profile is medium-high (5/7) reflecting equity market risk and sector concentration, but no complexity flags such as capital protection, structured features, or complex underlying assets are identified. Costs are straightforward with a single ongoing charge of 0.35% and no performance fees. The monthly factsheet confirms physical replication and direct equity holdings with low tracking error (~0.22% 1 year), no use of complex derivatives, and no leverage. No PRIIPs comprehension warnings or complexity disclaimers are present. Overall, the ETF exhibits a clear, linear exposure to a transparent equity index with minimal derivative use, no leverage, and no complex underlying assets, supporting a non-complex classification under MiFID II."
}